STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

CRVO Schedule 13G/A filing by Morgan Stanley

Morgan Stanley reported beneficial ownership of 739.7K shares, representing 8% of CervoMed Inc. in this filing.

FiledMay 11, 2026
Ownership dateMar 31, 2026
Reported shares739.7K
Reported ownership8%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 0
Shared voting power 736.6K
Sole dispositive power 0
Shared dispositive power 739.7K
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$3.80as of May 11, 2026
Latest tracked price$2.76as of Aug 6, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
Morgan Stanley
CIK
CIK0000895421
Accession
0000895421-26-000136
Form
Schedule 13G/A
Open SEC filing View CRVO ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →